nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—POR—Doxorubicin—peripheral nervous system neoplasm	0.376	0.453	CbGbCtD
Benzphetamine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.167	0.202	CbGbCtD
Benzphetamine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0715	0.0863	CbGbCtD
Benzphetamine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0552	0.0666	CbGbCtD
Benzphetamine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0513	0.0619	CbGbCtD
Benzphetamine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0479	0.0579	CbGbCtD
Benzphetamine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0236	0.0284	CbGbCtD
Benzphetamine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0216	0.0261	CbGbCtD
Benzphetamine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0147	0.0178	CbGbCtD
Benzphetamine—Cardiomyopathy—Isotretinoin—peripheral nervous system neoplasm	0.00723	0.0464	CcSEcCtD
Benzphetamine—Cardiomyopathy—Tretinoin—peripheral nervous system neoplasm	0.00723	0.0464	CcSEcCtD
Benzphetamine—Cardiomyopathy—Alitretinoin—peripheral nervous system neoplasm	0.00548	0.0351	CcSEcCtD
Benzphetamine—Digestion impaired—Melphalan—peripheral nervous system neoplasm	0.00546	0.035	CcSEcCtD
Benzphetamine—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.00262	0.0168	CcSEcCtD
Benzphetamine—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.00262	0.0168	CcSEcCtD
Benzphetamine—Cardiomyopathy—Epirubicin—peripheral nervous system neoplasm	0.0024	0.0154	CcSEcCtD
Benzphetamine—Cardiomyopathy—Doxorubicin—peripheral nervous system neoplasm	0.00222	0.0142	CcSEcCtD
Benzphetamine—Sweating—Topotecan—peripheral nervous system neoplasm	0.002	0.0128	CcSEcCtD
Benzphetamine—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.0127	CcSEcCtD
Benzphetamine—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00198	0.0127	CcSEcCtD
Benzphetamine—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00198	0.0127	CcSEcCtD
Benzphetamine—Trimethaphan—BCHE—peripheral nervous system neoplasm	0.00172	0.29	CrCbGaD
Benzphetamine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00151	0.00972	CcSEcCtD
Benzphetamine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00151	0.00972	CcSEcCtD
Benzphetamine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00964	CcSEcCtD
Benzphetamine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00149	0.00953	CcSEcCtD
Benzphetamine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00149	0.00953	CcSEcCtD
Benzphetamine—Sweating—Vincristine—peripheral nervous system neoplasm	0.00145	0.00929	CcSEcCtD
Benzphetamine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.00916	CcSEcCtD
Benzphetamine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00143	0.00916	CcSEcCtD
Benzphetamine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00129	0.00826	CcSEcCtD
Benzphetamine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00129	0.00826	CcSEcCtD
Benzphetamine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00129	0.00825	CcSEcCtD
Benzphetamine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00128	0.00818	CcSEcCtD
Benzphetamine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.00818	CcSEcCtD
Benzphetamine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00127	0.00815	CcSEcCtD
Benzphetamine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00127	0.00813	CcSEcCtD
Benzphetamine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00126	0.00807	CcSEcCtD
Benzphetamine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00126	0.00807	CcSEcCtD
Benzphetamine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00124	0.00796	CcSEcCtD
Benzphetamine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00765	CcSEcCtD
Benzphetamine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00765	CcSEcCtD
Benzphetamine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00117	0.00751	CcSEcCtD
Benzphetamine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00745	CcSEcCtD
Benzphetamine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00745	CcSEcCtD
Benzphetamine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00116	0.00742	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00115	0.00737	CcSEcCtD
Benzphetamine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00736	CcSEcCtD
Benzphetamine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00736	CcSEcCtD
Benzphetamine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00736	CcSEcCtD
Benzphetamine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00115	0.00735	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00731	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00731	CcSEcCtD
Benzphetamine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00113	0.00726	CcSEcCtD
Benzphetamine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00722	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00112	0.00721	CcSEcCtD
Benzphetamine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.00109	0.185	CrCbGaD
Benzphetamine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00108	0.00696	CcSEcCtD
Benzphetamine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00695	CcSEcCtD
Benzphetamine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00106	0.00678	CcSEcCtD
Benzphetamine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00672	CcSEcCtD
Benzphetamine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00672	CcSEcCtD
Benzphetamine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00103	0.00664	CcSEcCtD
Benzphetamine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00659	CcSEcCtD
Benzphetamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00098	0.00629	CcSEcCtD
Benzphetamine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000978	0.00627	CcSEcCtD
Benzphetamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000976	0.00626	CcSEcCtD
Benzphetamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000972	0.00624	CcSEcCtD
Benzphetamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000972	0.00624	CcSEcCtD
Benzphetamine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000967	0.0062	CcSEcCtD
Benzphetamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000959	0.00615	CcSEcCtD
Benzphetamine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000953	0.00611	CcSEcCtD
Benzphetamine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000937	0.00601	CcSEcCtD
Benzphetamine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000931	0.00597	CcSEcCtD
Benzphetamine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000918	0.00589	CcSEcCtD
Benzphetamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00091	0.00584	CcSEcCtD
Benzphetamine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000904	0.0058	CcSEcCtD
Benzphetamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000903	0.00579	CcSEcCtD
Benzphetamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000903	0.00579	CcSEcCtD
Benzphetamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000891	0.00572	CcSEcCtD
Benzphetamine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00088	0.00565	CcSEcCtD
Benzphetamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000879	0.00564	CcSEcCtD
Benzphetamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000872	0.0056	CcSEcCtD
Benzphetamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000872	0.0056	CcSEcCtD
Benzphetamine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000871	0.00559	CcSEcCtD
Benzphetamine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000869	0.00558	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000863	0.00554	CcSEcCtD
Benzphetamine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000838	0.00537	CcSEcCtD
Benzphetamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000833	0.00534	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000832	0.00534	CcSEcCtD
Benzphetamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000831	0.00533	CcSEcCtD
Benzphetamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000827	0.0053	CcSEcCtD
Benzphetamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000827	0.0053	CcSEcCtD
Benzphetamine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000824	0.00528	CcSEcCtD
Benzphetamine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000812	0.00521	CcSEcCtD
Benzphetamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000795	0.0051	CcSEcCtD
Benzphetamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000794	0.0051	CcSEcCtD
Benzphetamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00079	0.00507	CcSEcCtD
Benzphetamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000784	0.00503	CcSEcCtD
Benzphetamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000784	0.00503	CcSEcCtD
Benzphetamine—SLC18A2—ganglion—peripheral nervous system neoplasm	0.000781	0.142	CbGeAlD
Benzphetamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000774	0.00496	CcSEcCtD
Benzphetamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000762	0.00489	CcSEcCtD
Benzphetamine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000755	0.00484	CcSEcCtD
Benzphetamine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000744	0.00477	CcSEcCtD
Benzphetamine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000741	0.00475	CcSEcCtD
Benzphetamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000738	0.00473	CcSEcCtD
Benzphetamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000737	0.00473	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000736	0.00472	CcSEcCtD
Benzphetamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00071	0.00455	CcSEcCtD
Benzphetamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000684	0.00439	CcSEcCtD
Benzphetamine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000678	0.00435	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000674	0.00432	CcSEcCtD
Benzphetamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000661	0.00424	CcSEcCtD
Benzphetamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000659	0.00423	CcSEcCtD
Benzphetamine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000658	0.00422	CcSEcCtD
Benzphetamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000641	0.00411	CcSEcCtD
Benzphetamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000637	0.00409	CcSEcCtD
Benzphetamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000628	0.00403	CcSEcCtD
Benzphetamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000626	0.00402	CcSEcCtD
Benzphetamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00062	0.00398	CcSEcCtD
Benzphetamine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000609	0.0039	CcSEcCtD
Benzphetamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000604	0.00387	CcSEcCtD
Benzphetamine—SLC6A3—nerve—peripheral nervous system neoplasm	0.000598	0.109	CbGeAlD
Benzphetamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000594	0.00381	CcSEcCtD
Benzphetamine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00059	0.107	CbGeAlD
Benzphetamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000583	0.00374	CcSEcCtD
Benzphetamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000575	0.00369	CcSEcCtD
Benzphetamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000572	0.00367	CcSEcCtD
Benzphetamine—Toremifene—ABCB1—peripheral nervous system neoplasm	0.000544	0.0918	CrCbGaD
Benzphetamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000534	0.00343	CcSEcCtD
Benzphetamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000516	0.00331	CcSEcCtD
Benzphetamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000506	0.00325	CcSEcCtD
Benzphetamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000493	0.00316	CcSEcCtD
Benzphetamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000489	0.00314	CcSEcCtD
Benzphetamine—SLC6A2—nerve—peripheral nervous system neoplasm	0.000482	0.0876	CbGeAlD
Benzphetamine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000476	0.0865	CbGeAlD
Benzphetamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000474	0.00304	CcSEcCtD
Benzphetamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000464	0.00297	CcSEcCtD
Benzphetamine—SLC6A3—Parkinsons Disease Pathway—PINK1—peripheral nervous system neoplasm	0.000458	0.106	CbGpPWpGaD
Benzphetamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.00292	CcSEcCtD
Benzphetamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.00281	CcSEcCtD
Benzphetamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000427	0.00274	CcSEcCtD
Benzphetamine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000423	0.00271	CcSEcCtD
Benzphetamine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00268	CcSEcCtD
Benzphetamine—POR—trigeminal ganglion—peripheral nervous system neoplasm	0.000402	0.0731	CbGeAlD
Benzphetamine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000396	0.00254	CcSEcCtD
Benzphetamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.00253	CcSEcCtD
Benzphetamine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.00251	CcSEcCtD
Benzphetamine—SLC18A2—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.000391	0.0906	CbGpPWpGaD
Benzphetamine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.00248	CcSEcCtD
Benzphetamine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000385	0.00247	CcSEcCtD
Benzphetamine—Propafenone—ABCB1—peripheral nervous system neoplasm	0.000383	0.0647	CrCbGaD
Benzphetamine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00244	CcSEcCtD
Benzphetamine—POR—parotid gland—peripheral nervous system neoplasm	0.000379	0.0689	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000378	0.00242	CcSEcCtD
Benzphetamine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.00235	CcSEcCtD
Benzphetamine—Selegiline—ABCB1—peripheral nervous system neoplasm	0.000364	0.0615	CrCbGaD
Benzphetamine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.00229	CcSEcCtD
Benzphetamine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.00226	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.00224	CcSEcCtD
Benzphetamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000348	0.00223	CcSEcCtD
Benzphetamine—Bepridil—ABCB1—peripheral nervous system neoplasm	0.000341	0.0577	CrCbGaD
Benzphetamine—SLC18A2—brainstem—peripheral nervous system neoplasm	0.000339	0.0616	CbGeAlD
Benzphetamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.000338	0.0784	CbGpPWpGaD
Benzphetamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00207	CcSEcCtD
Benzphetamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.00206	CcSEcCtD
Benzphetamine—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.000314	0.053	CrCbGaD
Benzphetamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000299	0.00192	CcSEcCtD
Benzphetamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00191	CcSEcCtD
Benzphetamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00186	CcSEcCtD
Benzphetamine—Phenytoin—ABCB1—peripheral nervous system neoplasm	0.000285	0.0481	CrCbGaD
Benzphetamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.00178	CcSEcCtD
Benzphetamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00176	CcSEcCtD
Benzphetamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00172	CcSEcCtD
Benzphetamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00167	CcSEcCtD
Benzphetamine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.000257	0.0466	CbGeAlD
Benzphetamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00163	CcSEcCtD
Benzphetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—TH—peripheral nervous system neoplasm	0.000247	0.0572	CbGpPWpGaD
Benzphetamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00154	CcSEcCtD
Benzphetamine—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.000227	0.0384	CrCbGaD
Benzphetamine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000219	0.0369	CrCbGaD
Benzphetamine—Tamoxifen—ABCB1—peripheral nervous system neoplasm	0.000217	0.0367	CrCbGaD
Benzphetamine—Methadone—ABCB1—peripheral nervous system neoplasm	0.000215	0.0364	CrCbGaD
Benzphetamine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000207	0.0376	CbGeAlD
Benzphetamine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000192	0.035	CbGeAlD
Benzphetamine—SLC18A2—Dopaminergic Neurogenesis—TH—peripheral nervous system neoplasm	0.000185	0.043	CbGpPWpGaD
Benzphetamine—POR—cerebellum—peripheral nervous system neoplasm	0.000176	0.0319	CbGeAlD
Benzphetamine—SLC18A2—cerebellum—peripheral nervous system neoplasm	0.000167	0.0304	CbGeAlD
Benzphetamine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000165	0.03	CbGeAlD
Benzphetamine—ADRA1A—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.000152	0.0352	CbGpPWpGaD
Benzphetamine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000127	0.023	CbGeAlD
Benzphetamine—SLC6A2—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000118	0.0275	CbGpPWpGaD
Benzphetamine—SLC6A3—Dopaminergic Neurogenesis—TH—peripheral nervous system neoplasm	0.000111	0.0256	CbGpPWpGaD
Benzphetamine—SLC6A3—Alpha-synuclein signaling—TH—peripheral nervous system neoplasm	0.000108	0.025	CbGpPWpGaD
Benzphetamine—SLC6A3—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000105	0.0243	CbGpPWpGaD
Benzphetamine—ADRA1A—cerebellum—peripheral nervous system neoplasm	9.49e-05	0.0172	CbGeAlD
Benzphetamine—SLC6A3—Parkinsons Disease Pathway—TH—peripheral nervous system neoplasm	9.15e-05	0.0212	CbGpPWpGaD
Benzphetamine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	7.8e-05	0.0181	CbGpPWpGaD
Benzphetamine—ADRA2A—cerebellum—peripheral nervous system neoplasm	7.22e-05	0.0131	CbGeAlD
Benzphetamine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	6.62e-05	0.0154	CbGpPWpGaD
Benzphetamine—ADRA1A—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	6.47e-05	0.015	CbGpPWpGaD
Benzphetamine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.67e-05	0.0131	CbGpPWpGaD
Benzphetamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.4e-05	0.0125	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (z) signalling events—GNAS—peripheral nervous system neoplasm	4.69e-05	0.0109	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	4.32e-05	0.01	CbGpPWpGaD
Benzphetamine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	4.27e-05	0.0099	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	4.11e-05	0.00953	CbGpPWpGaD
Benzphetamine—ADRA2A—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	3.79e-05	0.00879	CbGpPWpGaD
Benzphetamine—SLC6A3—Parkinsons Disease Pathway—CASP3—peripheral nervous system neoplasm	3.72e-05	0.00863	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	3.68e-05	0.00852	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	3.57e-05	0.00827	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.34e-05	0.00775	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—BCHE—peripheral nervous system neoplasm	3.31e-05	0.00768	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.21e-05	0.00744	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	3.16e-05	0.00733	CbGpPWpGaD
Benzphetamine—ADRA2A—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	3.05e-05	0.00707	CbGpPWpGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	2.98e-05	0.00691	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—HGF—peripheral nervous system neoplasm	2.74e-05	0.00634	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	2.72e-05	0.00631	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	2.58e-05	0.00597	CbGpPWpGaD
Benzphetamine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.57e-05	0.00597	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	2.53e-05	0.00586	CbGpPWpGaD
Benzphetamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.45e-05	0.00569	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	2.42e-05	0.00562	CbGpPWpGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	2.4e-05	0.00556	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.25e-05	0.00521	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.16e-05	0.00501	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.07e-05	0.0048	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.99e-05	0.00462	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	1.99e-05	0.00461	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—BCHE—peripheral nervous system neoplasm	1.97e-05	0.00458	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	1.94e-05	0.00449	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	1.93e-05	0.00446	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.91e-05	0.00444	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	1.85e-05	0.00428	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	1.85e-05	0.00428	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.7e-05	0.00394	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	1.65e-05	0.00383	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	1.5e-05	0.00348	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	1.48e-05	0.00343	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.43e-05	0.00331	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	1.43e-05	0.00331	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.37e-05	0.00317	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.34e-05	0.00311	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.34e-05	0.00311	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	1.25e-05	0.0029	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	1.25e-05	0.0029	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.22e-05	0.00283	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.17e-05	0.00272	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	1.15e-05	0.00266	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.00265	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.14e-05	0.00263	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.09e-05	0.00252	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.06e-05	0.00247	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.02e-05	0.00236	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.01e-05	0.00235	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.01e-05	0.00235	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1e-05	0.00233	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	9.88e-06	0.00229	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	9.68e-06	0.00224	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.66e-06	0.00224	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.47e-06	0.0022	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.31e-06	0.00216	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.2e-06	0.00213	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.05e-06	0.0021	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.02e-06	0.00209	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.88e-06	0.00206	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.65e-06	0.00201	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IFNB1—peripheral nervous system neoplasm	8.35e-06	0.00194	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.25e-06	0.00191	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.15e-06	0.00189	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.14e-06	0.00189	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.06e-06	0.00187	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.99e-06	0.00185	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—HRAS—peripheral nervous system neoplasm	7.77e-06	0.0018	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—KNG1—peripheral nervous system neoplasm	7.74e-06	0.00179	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.57e-06	0.00175	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.49e-06	0.00174	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.44e-06	0.00172	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GNS—peripheral nervous system neoplasm	6.98e-06	0.00162	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.91e-06	0.0016	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	6.77e-06	0.00157	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	6.69e-06	0.00155	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	6.54e-06	0.00152	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	6.44e-06	0.00149	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	6.44e-06	0.00149	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.28e-06	0.00146	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	6.27e-06	0.00145	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.09e-06	0.00141	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.05e-06	0.0014	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	6.04e-06	0.0014	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.03e-06	0.0014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.02e-06	0.0014	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.84e-06	0.00135	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.6e-06	0.0013	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.26e-06	0.00122	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.89e-06	0.00113	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.78e-06	0.00111	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.76e-06	0.0011	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.7e-06	0.00109	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	4.63e-06	0.00107	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.6e-06	0.00107	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.44e-06	0.00103	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.42e-06	0.00103	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.41e-06	0.00102	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.39e-06	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.28e-06	0.000991	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	4.23e-06	0.000981	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.18e-06	0.000969	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.11e-06	0.000954	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.08e-06	0.000947	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	3.97e-06	0.000919	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.88e-06	0.0009	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	3.57e-06	0.000829	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.54e-06	0.000821	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.41e-06	0.00079	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	3.36e-06	0.000779	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	3.35e-06	0.000777	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.3e-06	0.000765	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.2e-06	0.000741	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	3.15e-06	0.00073	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.07e-06	0.000711	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.97e-06	0.00069	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.9e-06	0.000673	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.85e-06	0.000661	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.83e-06	0.000655	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.82e-06	0.000654	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.74e-06	0.000636	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	2.74e-06	0.000636	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.7e-06	0.000626	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	2.69e-06	0.000624	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.69e-06	0.000624	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.62e-06	0.000608	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	2.57e-06	0.000596	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.52e-06	0.000585	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.5e-06	0.00058	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.47e-06	0.000572	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.29e-06	0.000532	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	2.16e-06	0.000501	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.07e-06	0.000479	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.83e-06	0.000423	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.8e-06	0.000418	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.75e-06	0.000405	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.72e-06	0.000398	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.62e-06	0.000376	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.59e-06	0.00037	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.52e-06	0.000353	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.45e-06	0.000337	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.43e-06	0.000332	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.36e-06	0.000314	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.28e-06	0.000296	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.26e-06	0.000292	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.24e-06	0.000288	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-06	0.000285	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.19e-06	0.000275	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-06	0.000271	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.15e-06	0.000268	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.15e-06	0.000266	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.14e-06	0.000265	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-06	0.000261	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.05e-06	0.000243	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-06	0.000239	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.61e-07	0.000223	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.58e-07	0.000222	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.93e-07	0.000207	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.89e-07	0.000183	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.55e-07	0.000175	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	7.4e-07	0.000172	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.33e-07	0.00017	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.01e-07	0.000163	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	6.94e-07	0.000161	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.66e-07	0.000154	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.19e-07	0.000144	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-07	7.31e-05	CbGpPWpGaD
